UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Fortress Private Lending Fund

(Exact name of Registrant as Specified in Its Charter)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.02 Unregistered Sales of Unregistered Securities.

During January 2026, Fortress Private Lending Fund (the “Company”) sold its Class I common shares of beneficial interest, par value $0.01 per share (the “Shares”) for aggregate consideration of $121.5 million. The number of Shares to be issued was finalized on January 21, 2026. The purchase price per Share equaled the Company’s net asset value (“NAV”) per Share as of December 31, 2025. The offer and sale of the Shares was made pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), Regulation D promulgated thereunder and other available exemptions from the registration requirements of the Securities Act to investors who are “accredited investors” within the meaning of Regulation D under the Securities Act.

Item 8.01 Other Events.

Net Asset Value

The NAV per Share as of December 31, 2025, as determined in accordance with the valuation policies and procedures approved by the Company’s board of trustees, was as follows:

As of December 31, 2025, the Company’s aggregate NAV was approximately $859.9 million, the fair value of its portfolio investments was approximately $1.5 billion, and there was approximately $657.5 million debt outstanding.

January Distribution

On January 25, 2026, the Company declared a distribution for the monthly earnings period of January 2026 on the Shares (the “January 2026 Distribution”) in the amount per Share set forth below:

The distribution for the Shares is payable to shareholders of record as of the closing of business on January 31, 2026 and will be paid on or about February 24, 2026. The January 2026 Distribution will be paid in cash or reinvested in Shares for shareholders participating in the Company’s distribution reinvestment plan.

Portfolio and Business Commentary

As of December 31, 2025, the Company's portfolio was approximately $1.5 billion based on fair market value across 76 portfolio companies and 33 industries. Based on fair value, the Company's portfolio consisted of approximately 98.92% first lien, floating rate debt investments. The Company's portfolio’s directly originated debt investments had a median EBITDA of $84.3 million, a weighted average net loan-to-value and interest coverage of 45.01% and of 3.1x, respectively. The weighted average yield at fair market value of directly originated debt investments was 10.16% and the weighted average yield at fair market value of the overall portfolio was 9.67%. The Company had approximately $510 million of available liquidity as of December 31, 2025, comprised of cash and cash equivalents (offset by net receivable for investments sold and payable for investments purchased as of December 31, 2025) plus capacity to draw from credit facilities, subject to limitations related to the respective facility's borrowing base. From August 1, 2025 (date of the Company's BDC election) to December 31, 2025, the Company's portfolio closed $787 million of private loan commitments, increasing the portfolio’s private loan exposure from 51% to 73% on a fair market value basis.

The information presented above is based on management's preliminary determinations as of January 21, 2026. Consequently, the data set forth in our subsequent Annual Report on Form 10-K, which will include audited financial statements for the fiscal year ended December 31, 2025, may differ from this information, and any such differences may be material. In addition, the information presented above does not include all of the information regarding our financial condition and results of operations that may be important to investors. As a result, investors are cautioned not to place undue reliance on the information presented above.

Status of the Offering

The Company is currently offering on a continuous basis, Shares in transactions exempt from the registration provisions of the Securities Act, pursuant to Section 4(a)(2) thereof, by Rule 506(b) of Regulation D promulgated thereunder and Regulation S promulgated thereunder. As of the date hereof, the Company has issued a total of 39,677,284 Shares for aggregate consideration of $989.8 million. The Shares issued amount does not include Shares issued through the Company’s distribution reinvestment plan.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated January 27, 2026